Speaking as an MD, the evidence for medical marijuana is, uh, pretty thin . In fact, most people would decry the mismatch of research to marketing if it were a traditionally prescribed drug. The barriers to meaningful research are coming down, but the research just isn't there yet. I suspect that therapeutic targets will emerge, but no amount of enthusiasm changes the fact that high-quality research hasn't happened y…
Actually a lot of the data we have seen so far is quite good, here are some examples Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review https://jama.jamanetwork.com/article.aspx?articleid=2338266 Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
The from the second:
CBD has neuroprotective and antiinflammatory effects, and it appears to be well tolerated in humans, but small and methodologically limited studies of CBD in human epilepsy have been inconclusive. More recent anecdotal reports of high-ratio CBD:Δ9-THC medical marijuana have claimed efficacy, but studies were not controlled. CBD bears investigation in epilepsy and other neuropsychiatric disorders, including anxiety, schizophrenia, addiction, and neonatal hypoxic-ischemic encephalopathy. However, we lack data from well-powered double-blind randomized, controlled studies on the efficacy of pure CBD for any disorder. Initial dose-tolerability and double-blind randomized, controlled studies focusing on target intractable epilepsy populations such as patients with Dravet and Lennox-Gastaut syndromes are being planned. Trials in other treatment-resistant epilepsies may also be warranted.
This is not good evidence.
I want to be clear: I'm hopeful about the potential, but so far the enthusiasm for marijuana is not yet supported.